• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

    14.24 -0.12 (-0.84%)
    Streaming Delayed Price Updated: 11:42 AM EDT, Aug 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 15,545
    Open 14.22
    Bid (Size) 14.12 (100)
    Ask (Size) 14.28 (100)
    Prev. Close 14.36
    Today's Range 13.96 - 14.38
    52wk Range 12.96 - 20.90
    Shares Outstanding 407,265,944
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Amarin (AMRN) Q2 2026 Earnings Call Transcript ↗
    Amarin narrows losses while expanding global market reach across 22 countries. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Amarin Q2 Earnings Call Highlights ↗
    Amarin (NASDAQ:AMRN) said its second-quarter results reflected progress in its dual commercial strategy, which combines a company-managed U.S. business with partnered commercialization internationally.... 
    Via MarketBeat
    Topics Earnings

    Performance

    YTD
    +3.8%
    +3.8%
    1 Month
    -4.3%
    -4.3%
    3 Month
    -5.2%
    -5.2%
    6 Month
    -3.5%
    -3.5%
    1 Year
    -4.7%
    -4.7%

    More News

    Read More
    Amarin Posts Surprise Q2 Profit on Cost Discipline, Shares Rise Pre-Market (NASDAQ:AMRN) ↗
    Via Chartmill
    News headline image
    Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence
    From Amarin Corporation plc
    Via GlobeNewswire
    Amarin (NASDAQ:AMRN) Surprises with Revenue Beat but EPS Falls Short Amid Restructuring Costs ↗
    Via Chartmill
    Amarin Corp (NASDAQ:AMRN) Narrows Losses and Beats Adjusted EPS in Q4 2025 ↗
    Via Chartmill
    News headline image
    Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026
    From Amarin Corporation plc
    Via GlobeNewswire
    News headline image
    Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape
    From Amarin Corporation plc
    Via GlobeNewswire
    News headline image
    New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
    From Amarin Corporation plc
    Via GlobeNewswire
    News headline image
    Amarin (AMRN) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Amarin Reports 2026 First Quarter Financial Results
    From Amarin Corporation plc
    Via GlobeNewswire
    News headline image
    Amarin (AMRN) Q2 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Amarin (AMRN) Q3 2025 Earnings Transcript ↗
    Via The Motley Fool
    Topics World Trade
    News headline image
    Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026
    From Amarin Corporation plc
    Via GlobeNewswire
    News headline image
    Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline
    From Amarin Corporation plc
    Via GlobeNewswire
    News headline image
    New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual
    From Amarin Corporation plc
    Via GlobeNewswire
    News headline image
    Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Forget Amarin: This Oft-Overlooked Pharma Powerhouse Is a Better Buy Now ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology
    From Amarin Corporation plc
    Via GlobeNewswire
    News headline image
    Amarin (AMRN) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Amarin Reports Fourth Quarter and Full Year 2025 Financial Results
    From Amarin Corporation plc
    Via GlobeNewswire
    News headline image
    This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease
    From Amarin Corporation plc
    Via GlobeNewswire
    News headline image
    Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026
    From Amarin Corporation plc
    Via GlobeNewswire
    News headline image
    Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization
    From Amarin Corporation plc
    Via GlobeNewswire

    Frequently Asked Questions

    Is Amarin Corporation plc - American Depositary Shares publicly traded?
    Yes, Amarin Corporation plc - American Depositary Shares is publicly traded.
    What exchange does Amarin Corporation plc - American Depositary Shares trade on?
    Amarin Corporation plc - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Amarin Corporation plc - American Depositary Shares?
    The ticker symbol for Amarin Corporation plc - American Depositary Shares is AMRN on the Nasdaq Stock Market
    What is the current price of Amarin Corporation plc - American Depositary Shares?
    The current price of Amarin Corporation plc - American Depositary Shares is 14.24
    When was Amarin Corporation plc - American Depositary Shares last traded?
    The last trade of Amarin Corporation plc - American Depositary Shares was at 08/10/26 11:42 AM ET
    What is the market capitalization of Amarin Corporation plc - American Depositary Shares?
    The market capitalization of Amarin Corporation plc - American Depositary Shares is 5.80B
    How many shares of Amarin Corporation plc - American Depositary Shares are outstanding?
    Amarin Corporation plc - American Depositary Shares has 6B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.